Leesa Gentry insider trades
Open-market stock purchases and sales by Leesa Gentry, Chief Clinical Officer at RenovoRx, Inc, from SEC Form 4 filings since Mar 6, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 3, 2026 | RNXT RenovoRx, Inc | Bought (not open market) | — |
Companies traded
- RNXT RenovoRx, Inc: other filings, last Apr 3, 2026